瘤细胞上的TIGIT表达是成年T细胞白血病/淋巴瘤的不良预后因素

Yuichi Yamada1, Hiroaki Miyoshi2, Mai Takeuchi2

  • 1Department of Pathology, Kurume University School of Medicine, Kurume, Japan; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Pathology
|September 12, 2024
PubMed
概括

在成人T细胞白血病/淋巴瘤 (ATLL) 中,免疫球蛋白和免疫受体氨酸基抑制动机域 (TIGIT) 表达的T细胞免疫受体增加与较差的生存率有关. 这一发现强调了TIGIT作为ATLL患者潜在的预后标志物.